Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Schorlemer, C; Eber, E.
[Acute viral bronchiolitis and wheezy bronchitis in children].
Monatsschr Kinderheilkd. 2020; 9(9):1-11
Doi: 10.1007/s00112-020-00993-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Eber Ernst
-
Schorlemer Christina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Acute viral bronchiolitis and wheezy bronchitis are very common disorders in infants and preschool children. They are caused by viruses, particularly by respiratory syncytial virus and rhinoviruses. Risk factors for severe disease include premature birth, tobacco smoke exposure and immune dysfunctions. Patient history and a physical examination are sufficient to establish a diagnosis; chest X-ray and laboratory investigations are not routinely necessary. For acute bronchiolitis, many treatment options have been suggested but only supportive measures, such as minimal handling, securing adequate oxygenation and hydration are generally recommended. Antibiotics, bronchodilators, corticosteroids und leukotriene receptor antagonists are not routinely recommended. Short-acting beta-2 agonists are the first choice for the treatment of wheezy bronchitis. Inhaled corticosteroids may be tried to control symptoms in children with frequently recurring and/or severe episodes of wheezy bronchitis. The development of bronchial asthma, however, cannot be prevented by any pharmacologic tretament.
© The Author(s) 2020.
- Find related publications in this database (Keywords)
-
Respiratory syncytial virus
-
Risk factors
-
Oxygen
-
Beta-2 agonists
-
Asthma